Acalnib Capsule is a prescription targeted anticancer medicine used in the treatment of certain blood cancers. Commonly contains Acalabrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor. Used in patients with chronic lymphocytic leukemia (CLL) and related conditions.
🔹 Key Uses
Treatment of chronic lymphocytic leukemia (CLL)
Management of small lymphocytic lymphoma (SLL)
Used in mantle cell lymphoma (MCL)
Helps slow progression of cancer
🔹 Composition
Active ingredient: Acalabrutinib
Belongs to BTK inhibitor class
Used in targeted cancer therapy
🔹 How It Works
Blocks Bruton’s tyrosine kinase (BTK) enzyme
Inhibits growth and survival of cancer cells
Helps control progression of blood cancers
🔹 Key Benefits
Effective targeted therapy for blood cancers
Helps reduce cancer cell growth
Oral capsule for convenient administration
Improves disease control and outcomes
🔹 Dosage And Administration
Take as prescribed by an oncologist
Usually taken twice daily
Swallow whole with water
Follow strict treatment schedule
🔹 Possible Side Effects
Headache
Fatigue
Diarrhea
Muscle pain
Increased risk of infections
🔹 Precautions
Use under strict medical supervision
Regular blood tests required
Avoid grapefruit products
Inform doctor about all medications
Not recommended during pregnancy
Important: Always follow your healthcare provider's instructions when using this medication.
Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.
Hello! How can we help you today?
Our pharmaceutical experts typically reply in a few minutes.
Start Chat